Towards Immunotherapy-Induced Normalization of the Tumor Microenvironment.
Ontology highlight
ABSTRACT: Immunotherapies modulate the function of immune cells to eradicate cancer cells through various mechanisms. These therapies are successful across a spectrum of cancers, but they are curative only in a subset of patients. Indeed, a major obstacle to the success of immunotherapies is the immunosuppressive nature of the tumor microenvironment (TME), comprising the stromal component and immune infiltrate of tumors. Importantly, the TME in most solid cancers is characterized by sparsely perfused blood vessels resulting from so-called pathological angiogenesis. In brief, dysregulated development of new vessels results in leaky tumor blood vessels that inefficiently deliver oxygen and other nutrients. Moreover, the occurrence of dysregulated fibrosis around the lesion, known as pathological desmo
SUBMITTER: Melo V
PROVIDER: S-EPMC9196132 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA